Literature DB >> 9450928

p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation.

W L Kraus1, J T Kadonaga.   

Abstract

Estrogen- and antiestrogen-regulated, AF-2-dependent transcriptional activation by purified full-length human estrogen receptor (ER) was carried out with chromatin templates in vitro. With this system, the ability of purified human p300 to function as a transcriptional coactivator was examined. In the absence of ligand-activated ER, p300 was found to have little effect (less than twofold increase) on transcription, whereas, in contrast, p300 was observed to act synergistically with ligand-activated ER to enhance transcription. When transcription was limited to a single round, p300 and ER were found to enhance the efficiency of transcription initiation in a cooperative manner. On the other hand, when transcription reinitiation was allowed to occur, ER, but not p300, was able to increase the number of rounds of transcription. These results suggest a two-stroke mechanism for transcriptional activation by ligand-activated ER and p300. In the first stroke, ER and p300 function cooperatively to increase the efficiency of productive transcription initiation. In the second stroke, ER promotes the reassembly of the transcription preinitiation complex. Therefore, ER exhibits distinct, dual functions in transcription initiation and reinitiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9450928      PMCID: PMC316488          DOI: 10.1101/gad.12.3.331

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  81 in total

1.  A canonical structure for the ligand-binding domain of nuclear receptors.

Authors:  J M Wurtz; W Bourguet; J P Renaud; V Vivat; P Chambon; D Moras; H Gronemeyer
Journal:  Nat Struct Biol       Date:  1996-01

Review 2.  Steroid hormone receptors: many actors in search of a plot.

Authors:  M Beato; P Herrlich; G Schütz
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

Review 3.  The RXR heterodimers and orphan receptors.

Authors:  D J Mangelsdorf; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

4.  Adaptor-mediated recruitment of RNA polymerase II to a signal-dependent activator.

Authors:  B L Kee; J Arias; M R Montminy
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

5.  NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro.

Authors:  M J Pazin; P L Sheridan; K Cannon; Z Cao; J G Keck; J T Kadonaga; K A Jones
Journal:  Genes Dev       Date:  1996-01-01       Impact factor: 11.361

6.  Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens.

Authors:  D P McDonnell; D L Clemm; T Hermann; M E Goldman; J W Pike
Journal:  Mol Endocrinol       Date:  1995-06

7.  CBP as a transcriptional coactivator of c-Myb.

Authors:  P Dai; H Akimaru; Y Tanaka; D X Hou; T Yasukawa; C Kanei-Ishii; T Takahashi; S Ishii
Journal:  Genes Dev       Date:  1996-03-01       Impact factor: 11.361

8.  A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors.

Authors:  Y Kamei; L Xu; T Heinzel; J Torchia; R Kurokawa; B Gloss; S C Lin; R A Heyman; D W Rose; C K Glass; M G Rosenfeld
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

9.  Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor.

Authors:  W L Kraus; E M McInerney; B S Katzenellenbogen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

Review 10.  The nuclear receptor superfamily: the second decade.

Authors:  D J Mangelsdorf; C Thummel; M Beato; P Herrlich; G Schütz; K Umesono; B Blumberg; P Kastner; M Mark; P Chambon; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

View more
  116 in total

1.  p300 requires its histone acetyltransferase activity and SRC-1 interaction domain to facilitate thyroid hormone receptor activation in chromatin.

Authors:  J Li; B W O'Malley; J Wong
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

Review 2.  Chromatin modification and disease.

Authors:  C A Johnson
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

3.  p300-mediated acetylation facilitates the transfer of histone H2A-H2B dimers from nucleosomes to a histone chaperone.

Authors:  T Ito; T Ikehara; T Nakagawa; W L Kraus; M Muramatsu
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

4.  Cdc25B functions as a novel coactivator for the steroid receptors.

Authors:  Z Q Ma; Z Liu; E S Ngan; S Y Tsai
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

Review 5.  Estrogen receptors: orchestrators of pleiotropic cellular responses.

Authors:  J G Moggs; G Orphanides
Journal:  EMBO Rep       Date:  2001-09       Impact factor: 8.807

6.  The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to mediate transcriptional activation.

Authors:  K E Scoggin; A Ulloa; J K Nyborg
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

7.  ERAP140, a conserved tissue-specific nuclear receptor coactivator.

Authors:  Wenlin Shao; Shlomit Halachmi; Myles Brown
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

8.  p300 forms a stable, template-committed complex with chromatin: role for the bromodomain.

Authors:  E T Manning; T Ikehara; T Ito; J T Kadonaga; W L Kraus
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

9.  Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment.

Authors:  Charles E Foulds; Mary L Nelson; Adam G Blaszczak; Barbara J Graves
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

10.  p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha.

Authors:  Asmaà Fritah; Cécile Saucier; Jan Mester; Gérard Redeuilh; Michèle Sabbah
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.